Delivery Order SPE2DB20D1109-SPE2DB23FN66E
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of RabAvert rabies vaccine with diluents. The fixed-price delivery order has a ceiling value of $1,930.30 and an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of RabAvert rabies vaccine with diluents, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,033.42 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a leading global pharmaceutical distribution company, to supply RabAvert rabies vaccine with diluents. The contract has a ceiling value of $11,581.80 and a performance period through April 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC...
- This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The $3,860.60 firm fixed price delivery order has a completion date of November 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026 to provide a comprehensive range of medical commodities,...
- This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,951.97 firm fixed-price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 29, 2023. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award is for the delivery of RABAVERT RABIES VACC W-DILUENTS to the Defense Logistics Agency (DLA). The $9,178.15 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 3, 2023, with a completion date of March 6, 2023. The contract is not designated with any set-aside requirements. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of RabAvert rabies vaccine with diluents, with a ceiling value of $1,257.48. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed-price pricing type and has an ultimate completion date of January 31, 2025. This contract does not have a set-aside designation, indicating open...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply RabAvert rabies vaccine with diluents. The contract, valued at $24,552.90, has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation indicated. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $7,142.59 for the supply of RABAVERT Rabies Vaccine with diluents. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 15, 2024. The contract is not designated under any set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of RabAvert rabies vaccine with diluents. The award, valued at $2,702.42, is a firm fixed price delivery order contract with a completion date of March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. In addition to this specific award, Amerisourcebergen Drug Corp holds a...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FN66EDelivery Order
This federal contract award is for the delivery of RabAvert rabies vaccine with diluents, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,134.58 firm fixed-price delivery order has a completion date of March 3, 2023 and was awarded on March 2, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that larger IDC contract. The contract was awarded through full and open competition without any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 3/2/23 |